T1	Participants 391 571	Ninety-five patients from southwestern iowa and southeastern Nebraska were enrolled, of whom 88 were considered eligible for comparison (by continuing through week 2 of the study).
T2	Participants 585 650	Patients were randomized to an MR plan or a traditional RCD plan.
T3	Participants 651 760	Patients were followed for a 3-month period of active weight loss and a 10-week period of weight maintenance.
T4	Participants 761 853	Patients returned every 3 weeks for follow-up with the pharmacist, for a total of 13 visits.
